These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 17169558)
1. Synthesis and biological evaluation of new conformationally biased integrin ligands based on a tetrahydroazoninone scaffold. Banfi L; Basso A; Damonte G; De Pellegrini F; Galatini A; Guanti G; Monfardini I; Riva R; Scapolla C Bioorg Med Chem Lett; 2007 Mar; 17(5):1341-5. PubMed ID: 17169558 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, SAR and in vitro evaluation of new cyclic Arg-Gly-Asp pseudopentapeptides containing a s-cis peptide bond as integrin alphavbeta3 and alphavbeta5 ligands. Salvati M; Cordero FM; Pisaneschi F; Melani F; Gratteri P; Cini N; Bottoncetti A; Brandi A Bioorg Med Chem; 2008 Apr; 16(8):4262-71. PubMed ID: 18343671 [TBL] [Abstract][Full Text] [Related]
3. Morpholine-based RGD-cyclopentapeptides as alphavbeta3/alphavbeta5 integrin ligands: role of configuration towards receptor binding affinity. Cini N; Trabocchi A; Menchi G; Bottoncetti A; Raspanti S; Pupi A; Guarna A Bioorg Med Chem; 2009 Feb; 17(4):1542-9. PubMed ID: 19195898 [TBL] [Abstract][Full Text] [Related]
4. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins. Oba M; Fukushima S; Kanayama N; Aoyagi K; Nishiyama N; Koyama H; Kataoka K Bioconjug Chem; 2007; 18(5):1415-23. PubMed ID: 17595054 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of dual action cyclo-RGD/SMAC mimetic conjugates targeting α(v)β(3)/α(v)β(5) integrins and IAP proteins. Mingozzi M; Manzoni L; Arosio D; Dal Corso A; Manzotti M; Innamorati F; Pignataro L; Lecis D; Delia D; Seneci P; Gennari C Org Biomol Chem; 2014 May; 12(20):3288-302. PubMed ID: 24737345 [TBL] [Abstract][Full Text] [Related]
6. A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion. Hoffmann S; He S; Jin M; Ehren M; Wiedemann P; Ryan SJ; Hinton DR BMC Ophthalmol; 2005 Jun; 5():16. PubMed ID: 15987521 [TBL] [Abstract][Full Text] [Related]
7. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands. Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378 [TBL] [Abstract][Full Text] [Related]
8. Design and evaluation of benzophenone-containing conformationally constrained ligands as tools for photoaffinity scanning of the integrin alphaVbeta3-ligand bimolecular interaction. Bitan G; Scheibler L; Teng H; Rosenblatt M; Chorev M J Pept Res; 2000 Mar; 55(3):181-94. PubMed ID: 10727100 [TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus forms a multimolecular complex of integrins (alphaVbeta5, alphaVbeta3, and alpha3beta1) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the postentry stage of infection. Veettil MV; Sadagopan S; Sharma-Walia N; Wang FZ; Raghu H; Varga L; Chandran B J Virol; 2008 Dec; 82(24):12126-44. PubMed ID: 18829766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]